HLBBF
Price:
$6.6
Market Cap:
$32.93B
H. Lundbeck A/S operates as an international biopharmaceutical entity, focusing its efforts on the entire lifecycle of pharmaceutical products—from initial research and development to manufacturing and global sales. The firm primarily specializes in therapeutic solutions for psychiatric and neurological disorders across Europe, North America, and other worldwide regions. Among its prominent offerings are Abilify Maintena and Rexulti/Rxulti, prescribed for schizophrenia; Brintellix/Trintellix and Rexulti/Rxulti for the management of depression; Vyepti for the prevention of migraine attacks; and Northera, used to treat symptomatic neurogenic orthostatic hypotension. Lundbeck's diverse product ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-07-13
Stock Exchange
OTC
Ticker
HLBBF
According to H. Lundbeck A/S’s latest financial reports and current stock price. The company's current Current Ratio is 1.41. This represents a change of -4.84% compared to the average of 1.48 of the last 4 quarters.
The mean historical Current Ratio of H. Lundbeck A/S over the last ten years is 1.28. The current 1.41 Current Ratio has changed 10.93% with respect to the historical average. Over the past ten years (40 quarters), HLBBF's Current Ratio was at its highest in in the September 2024 quarter at 2.19. The Current Ratio was at its lowest in in the December 2019 quarter at 0.88.
Average
1.28
Median
1.38
Minimum
0.88
Maximum
1.66
Discovering the peaks and valleys of H. Lundbeck A/S Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 42.52%
Maximum Annual Current Ratio = 1.66
Minimum Annual Increase = -42.82%
Minimum Annual Current Ratio = 0.88
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 1.44 | -4.77% |
| 2024 | 1.52 | -8.83% |
| 2023 | 1.66 | 19.49% |
| 2022 | 1.39 | 42.52% |
| 2021 | 0.98 | -3.23% |
| 2020 | 1.01 | 14.80% |
| 2019 | 0.88 | -42.82% |
| 2018 | 1.54 | 12.64% |
| 2017 | 1.37 | 41.07% |
| 2016 | 0.97 | -2.13% |
The current Current Ratio of H. Lundbeck A/S (HLBBF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.54
5-year avg
1.40
10-year avg
1.28
H. Lundbeck A/S’s Current Ratio is less than Hikma Pharmaceuticals PLC (1.82), less than Hikma Pharmaceuticals PLC (1.82), less than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (1.60), less than Ono Pharmaceutical Co., Ltd. (2.86), less than Livzon Pharmaceutical Group Inc. (1.96), less than Ono Pharmaceutical Co., Ltd. (2.86), less than Siegfried Holding AG (2.00), greater than Sumitomo Pharma Co., Ltd. (1.03), greater than Sumitomo Pharma Co., Ltd. (1.03), less than Zealand Pharma A/S (37.17),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.82 | $4.08B | |
| 1.82 | $4.13B | |
| 1.60 | $6.20B | |
| 2.86 | $6.53B | |
| 1.96 | $6.06B | |
| 2.86 | $6.84B | |
| 2.00 | $3.69B | |
| 1.03 | $4.15B | |
| 1.03 | $4.22B | |
| 37.17 | $3.16B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like H. Lundbeck A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like H. Lundbeck A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is H. Lundbeck A/S's Current Ratio?
How is the Current Ratio calculated for H. Lundbeck A/S (HLBBF)?
What is the highest Current Ratio for H. Lundbeck A/S (HLBBF)?
What is the 3-year average Current Ratio for H. Lundbeck A/S (HLBBF)?
What is the 5-year average Current Ratio for H. Lundbeck A/S (HLBBF)?
How does the current Current Ratio for H. Lundbeck A/S (HLBBF) compare to its historical average?